molecules of the month


oral noncovalent hemoglobin (HbS) modulator

2:1 binding, high RBC partition.; in Ph. I w/ HV

from virtual screening, NMR confirm. and opt.

J. Med. Chem., Dec. 24, 2020

Pfizer, Groton, CT / Cambridge, MA

Structure of PF07059013
1 min read

Pfizer noncovalent oral hemoglobin (HbS) modulator

request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.

already a member? log in: